共 50 条
- [21] Comparison of efficacy and tolerability of amlodipine orotate versus amlodipine besylate in adult patients with mild to moderate hypertension: A multicenter, randomized, double-blind, placebo-controlled, parallel-group, 8-week follow-up, noninferiority trial CLINICAL THERAPEUTICS, 2006, 28 (04) : 537 - 551
- [22] COMPARISON OF AMLODIPINE AND BENAZEPRIL MONOTHERAPY TO AMLODIPINE PLUS BENAZEPRIL IN PATIENTS WITH SYSTEMIC HYPERTENSION - A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY JOURNAL OF CLINICAL PHARMACOLOGY, 1995, 35 (11): : 1060 - 1066
- [26] The efficacy and safety of fixed-dose combination of amlodipine/benazepril in Chinese essential hypertensive patients not adequately controlled with benazepril monotherapy: a multicenter, randomized, double-blind, double-dummy, parallel-group clinical trial CLINICAL AND EXPERIMENTAL HYPERTENSION, 2014, 36 (04) : 268 - 274
- [27] Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension CLINICAL THERAPEUTICS, 2007, 29 (04) : 563 - 580
- [28] Results of a multicenter, 8-week, parallel-group, randomized, double-blind, double-dummy, phase III clinical trial to evaluate the efficacy and tolerability of amlodipine maleate versus amlodipine besylate in Korean patients with mild to moderate hypertension CLINICAL THERAPEUTICS, 2005, 27 (04) : 441 - 450
- [29] A randomized, double-blind clinical trial to evaluate the efficacy and safety of a fixed-dose combination of amlodipine/rosuvastatin in patients with dyslipidemia and hypertension JOURNAL OF CLINICAL HYPERTENSION, 2020, 22 (02): : 261 - 269